B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Regulation of RUNX1 Expression and Activity

REACTOME PATHWAY
Reactome: R-HSA-89345935 genes25 compounds

The Regulation of RUNX1 Expression and Activity pathway (Reactome ID: R-HSA-8934593) involves 5 genes and is affected by 25 compounds in the BiohacksAI evidence corpus. Compound-pathway associations are derived from target overlap: a compound is linked to this pathway if it targets ≥2 genes within the pathway.

Genes in this Pathway

AGO2CBFBCDK6RUNX1SRC

Compounds Affecting Regulation of RUNX1 Expression and Activity

#CompoundTargets HitStudies
1Sorafenib300
2Aurintricarboxylic Acid184
3Dihydroxyphenylalanine300
4Disulfiram297
5Ethidium300
6juglone hydroxylase [Supplementary Concept] catalyzes279
7Daunorubicin298
8Fusaric Acid300
9Harmaline300
10Dasatinib299
11Resveratrol298
12tyrphostin ag 14784
13Quercetin300
14Adenosine Monophosphate Adenine nucleotide containing300
15Afatinib297
16alsterpaullone12
17Crizotinib298
18kenpaullone8
19monorden8
20Niclosamide299
21Apigenin 5,7,4'-trihydroxy-flavone,300
22chrysin300
23fisetin78
24indirubin300
25Sulfisomidine73

About the Regulation of RUNX1 Expression and Activity Pathway

The Regulation of RUNX1 Expression and Activity pathway is catalogued in Reactome (ID: R-HSA-8934593) and involves 5 genes. In the BiohacksAI corpus, 25 compounds have documented interactions with at least 2 genes in this pathway, establishing mechanistic relevance. Key pathway genes include AGO2, CBFB, CDK6, RUNX1, SRC.